Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23017 | 305 | 46.0 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
85 | 25913 | MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SFAS APO 1 | Author keyword | 2 | 67% | 1% | 2 |
2 | ACUTE RELAPSE | Author keyword | 1 | 50% | 1% | 2 |
3 | AMYLOID PEPTIDE A BETA | Author keyword | 1 | 50% | 0% | 1 |
4 | BAX DEFICIENT MICE | Author keyword | 1 | 50% | 0% | 1 |
5 | BIOMED D 12 | Address | 1 | 50% | 0% | 1 |
6 | BISINDOLYLMALEIMIDE VIII | Author keyword | 1 | 50% | 0% | 1 |
7 | BRAIN PRIMARY CULTURE | Author keyword | 1 | 50% | 0% | 1 |
8 | CANCEROL MOL | Address | 1 | 50% | 0% | 1 |
9 | DEMYELINATION REMYELINATION | Author keyword | 1 | 50% | 0% | 1 |
10 | FASCD95 | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SFAS APO 1 | 2 | 67% | 1% | 2 | Search SFAS+APO+1 | Search SFAS+APO+1 |
2 | ACUTE RELAPSE | 1 | 50% | 1% | 2 | Search ACUTE+RELAPSE | Search ACUTE+RELAPSE |
3 | AMYLOID PEPTIDE A BETA | 1 | 50% | 0% | 1 | Search AMYLOID+PEPTIDE+A+BETA | Search AMYLOID+PEPTIDE+A+BETA |
4 | BAX DEFICIENT MICE | 1 | 50% | 0% | 1 | Search BAX+DEFICIENT+MICE | Search BAX+DEFICIENT+MICE |
5 | BISINDOLYLMALEIMIDE VIII | 1 | 50% | 0% | 1 | Search BISINDOLYLMALEIMIDE+VIII | Search BISINDOLYLMALEIMIDE+VIII |
6 | BRAIN PRIMARY CULTURE | 1 | 50% | 0% | 1 | Search BRAIN+PRIMARY+CULTURE | Search BRAIN+PRIMARY+CULTURE |
7 | DEMYELINATION REMYELINATION | 1 | 50% | 0% | 1 | Search DEMYELINATION+REMYELINATION | Search DEMYELINATION+REMYELINATION |
8 | FASCD95 | 1 | 50% | 0% | 1 | Search FASCD95 | Search FASCD95 |
9 | FIVE COLOR FLOW CYTOMETRY | 1 | 50% | 0% | 1 | Search FIVE+COLOR+FLOW+CYTOMETRY | Search FIVE+COLOR+FLOW+CYTOMETRY |
10 | HWTX 1 | 1 | 50% | 0% | 1 | Search HWTX+1 | Search HWTX+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | V BETA 82 CELLS | 4 | 50% | 2% | 6 |
2 | INHIBITOR FLIP | 3 | 50% | 1% | 4 |
3 | FAIM | 2 | 67% | 1% | 2 |
4 | APOPTOSIS INHIBITORY MOLECULE | 2 | 50% | 1% | 3 |
5 | CD95 APO 1 FAS | 2 | 14% | 4% | 13 |
6 | BETA LYMPHOCYTES T | 1 | 50% | 1% | 2 |
7 | MAMMALIAN CASPASES | 1 | 27% | 1% | 3 |
8 | NEURODEGENERATION FOLLOWING TRAUMA | 1 | 50% | 0% | 1 |
9 | LIFEGUARD NEURONAL MEMBRANE PROTEIN 35 | 0 | 20% | 1% | 2 |
10 | DEATH LIGAND TRAIL | 0 | 14% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The role of T cell apoptosis in nervous system autoimmunity | 2012 | 15 | 104 | 29% |
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses | 2004 | 152 | 265 | 22% |
Death receptor Fas (CD95) signaling in the central nervous system: tuning neuroplasticity? | 2008 | 18 | 68 | 24% |
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis | 2012 | 8 | 156 | 20% |
Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system | 2007 | 13 | 127 | 28% |
Death receptor signalling in central nervous system inflammation and demyelination | 2011 | 15 | 109 | 18% |
Apoptosis in multiple sclerosis | 2000 | 41 | 79 | 34% |
Death ligands and autoimmune demyelination | 2006 | 24 | 62 | 21% |
Apoptosis in multiple sclerosis - etiopathogenetic relevance and perspectives for new therapeutic strategies | 2000 | 1 | 36 | 64% |
CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS | 2008 | 29 | 71 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMED D 12 | 1 | 50% | 0.3% | 1 |
2 | CANCEROL MOL | 1 | 50% | 0.3% | 1 |
3 | MED NEUROBIOL NEUROBIOL | 1 | 50% | 0.3% | 1 |
4 | RECERCA VAIL DHEBRON VHIR | 1 | 50% | 0.3% | 1 |
5 | TRANSIT UNIV LIMBURG | 1 | 50% | 0.3% | 1 |
6 | VIROL MYCOL IMMUNOL | 1 | 50% | 0.3% | 1 |
7 | FISIOLOXIA | 1 | 25% | 0.7% | 2 |
8 | CLIN COOPERAT UNIT MOL ONCOL PEDIAT | 0 | 33% | 0.3% | 1 |
9 | DRR DSV | 0 | 33% | 0.3% | 1 |
10 | NEUROIMMUNOL UNIV | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216853 | FAS//FAS LIGAND//AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
2 | 0.0000178518 | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//MYELIN OLIGODENDROCYTE GLYCOPROTEIN//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS |
3 | 0.0000154840 | NEUROONTOGENESIS//JCASP//FUNCT BIOCHEM NERVOUS SYST |
4 | 0.0000150249 | CSF CEREBROSPINAL FLUID//SOLUBLE VASCULAR CELL ADHESION MOLECULE 1 SVCAM 1//INTRAVENOUS METHYLPREDNISOLONE |
5 | 0.0000104861 | NEUROREHABIL WARD//PERINATAL BIOCHEM//ASTROCYTE SURVIVAL |
6 | 0.0000092830 | IMMUNOBIOL ROBERT H LURIE CANC//EXPT CLIN NEUROL//MS CLIN |
7 | 0.0000083786 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
8 | 0.0000077245 | PONTOSUBICULAR NECROSIS//INFANTILE BILATERAL STRIATAL NECROSIS//BRAINSTEM NECROSIS |
9 | 0.0000076159 | CELL BIOL IMMUNOL SECT//HUMAN NEURAL DEVELOPMENT//LEWIS THOMAS S 123 |
10 | 0.0000073327 | EXERCISE PHYSIOL MUSCLE BIOL SARCOPENIA//MUSCLE SARCOPENIA MUSCLE DIS//ROBERT C BYRD HLTH SCI MUSCLE BIOL SARC |